You are viewing the site in preview mode
Skip to main content
|
Characteristics
|
Value
|
|---|
|
Number of lymph nodes
|
90
|
|
Metastatic lymph nodes
|
65 (72.2%)
|
|
Benign lymph nodes
|
25 (27.7%)
|
|
Mean age (year)
|
|
Baseline (healthy subjects)
|
53.4 ± 4.1 (37–64)
|
|
Metastatic disease patients
|
62.3 ± 8.3 (41–82)
|
|
Sex (overall)
|
|
Male
|
59 (65.6%)
|
|
Female
|
31 (34.4%)
|
|
Primary HNSCC characteristics
|
|
Baseline
|
25 (27.7%)
|
|
Pharyngeal SCC
|
22 (24.4%)
|
|
Oropharyngeal SCC
|
12 (13.3%)
|
|
Hypopharyngeal SCC
|
10 (11.1%)
|
|
Laryngeal SCC
|
18 (20.0%)
|
|
Oral carcinoma
|
23 (25.6%)
|
|
Sinus carcinoma
|
2 (2.2%)
|
|
Pharyngeal SCC
|
27 (29.3%)
|
|
Tumor grade
|
|
Baseline
|
25 (27.7%)
|
|
Well differentiated
|
9 (10.0%)
|
|
Moderately differentiated
|
34 (37.8%)
|
|
Poorly differentiated
|
22 (24.4%)
|
|
T category
|
|
Baseline
|
25 (27.7%)
|
|
T1
|
8 (8.7%)
|
|
T2
|
27 (30.0%)
|
|
T3
|
30 (33.3%)
|
|
T4
|
25 (27.8%)
|
|
N category
|
|
Baseline
|
25 (27.7%)
|
|
N1
|
14 (15.6%)
|
|
N2
|
43 (46.7%)
|
|
N3
|
8 (8.9%)
|
|
M category
|
|
Baseline
|
25 (27.7%)
|
|
M0
|
56 (62.3%)
|
|
M1
|
9 (10.0%)
|
